CLINICAL_TRIALS
trial_result
· 2008-10-29
Clinical Trial Update: A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLS [Phase 3]
Summary
Phase 3 clinical trial evaluating cabergoline for restless legs syndrome has completed, assessing its efficacy and safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Restless Legs Syndrome | Phase 3 | Status: COMPLETED